Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001507650-26-000005

Co-Chief Executive Officer bought 100,000 shares at $14.60 ($1,460,000)

From the SEC's structured data for this filing

Trades in this filing

Zanganeh Mahkam · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-04 Purchase : show line 1 in the form +100,000 $14.60 $1,460,000 25,824,474 I
Open-market purchases · 100,000 sh · avg $14.60 · $1,460,000
Loading xslF345X06/wk-form4_1780609499.xml…